NOTCH2's role in joint inflammation
Role of NOTCH2 in Articular Inflammation
This work looks at how changes in the NOTCH2 gene make joint cells more inflamed and may contribute to osteoarthritis in people with joint degeneration.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Sch of Med/dnt NIH-funded |
| Lab location | 1 site (Farmington, United States) |
| Project ID | NIH-11370319 on NIH RePORTER |
What this research studies
Researchers use mouse models that carry a NOTCH2 change which makes joint cells react more strongly to inflammatory signals. They trigger joint injury in mice (destabilization of the medial meniscus) to model osteoarthritis and study which joint cells and pathways drive inflammation. Lab studies focus on how NOTCH2 changes increase responses to inflammatory molecules like TNFα and IL-1β in cartilage cells. The team also made a conditional NOTCH2 mouse to turn the change on in specific cell types to find the exact cells causing disease.
Who could benefit from this research
Good fit: Although the project uses mouse models and does not enroll patients, its findings would be most relevant to people with osteoarthritis or those at high risk for joint degeneration.
Not a fit: People without osteoarthritis or those whose joint problems are unrelated to inflammatory pathways may not see direct benefit from this research.
Why it matters
Potential benefit: If successful, this work could identify new molecular targets to reduce joint inflammation and slow or prevent osteoarthritis progression.
How similar studies have performed: Prior animal studies linked Notch activation to osteoarthritis and showed that blocking canonical Notch signaling can reduce disease in mouse models, while this project explores a gain-of-function NOTCH2 effect and novel non-canonical pathways.
Where this research is happening
Farmington, United States
- University of Connecticut Sch of Med/dnt — Farmington, United States (Active)
Researchers
- Principal investigator: Canalis, Ernesto — University of Connecticut Sch of Med/dnt
- Study coordinator: Canalis, Ernesto
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.